BACKGROUND The measurement of circulating anti-Müllerian hormone (AMH) has been
applied to a wide array of clinical applications, mainly based on its ability to reflect the …

BACKGROUND In women, anti-Müllerian hormone (AMH) is exclusively produced by
granulosa cells of ovarian follicles during the early stages of follicle development. After an …

BACKGROUND The main objective of individualization of treatment in IVF is to offer every
single woman the best treatment tailored to her own unique characteristics, thus maximizing …

BACKGROUND In women, anti-Müllerian hormone (AMH) levels may represent the ovarian
follicular pool and could be a useful marker of ovarian reserve. The clinical application of …

Context: There has been renewed interest in anti-Müllerian hormone (AMH) because of its
role in the ovary. Data on its actions are sparse, but it appears to inhibit follicle growth …

BACKGROUND The antral follicle count (AFC) and anti-Müllerian hormone (AMH) both
represent age-related follicular decline quite accurately, although long-term follow-up …

Background A high body mass index (BMI) has been associated with reduced semen quality
and male subfecundity, but no studies following obese men losing weight have yet been …

Reproductive aging is the decline of female fertility with age. It is caused by the decrease in
the number of growing follicles, resulting from primordial follicle pool depletion. Recently, we …

Anti‐Müllerian hormone (AMH) is a dimeric glycoprotein, a member of the transforming
growth factor (TGF) superfamily. It is produced exclusively in the gonads and is involved in …

Context: Anti-Müllerian hormone (AMH), which is secreted by immature Sertoli cells,
triggers the involution of the fetal Müllerian ducts. AMH is a testis-specific marker used for …